Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD and CBDV in Men With Autism Spectrum Disorder
NCT03537950Completed
- Sponsor
- King's College London
- Start
- Aug 2016
- Primary completion
- Feb 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of cannabidiol and cannabidivarin in Autism Spectrum Disorder (ASD), sponsored by King's College London. Started Aug 2016; status: completed.
02
Drugs
cannabidiolcannabidivarin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03537950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03537950.